Erratum: Change original to "Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty".

IF 1.6 Q3 ALLERGY

Asia Pacific Allergy Pub Date : 2022-10-31 eCollection Date: 2022-10-01 DOI:10.5415/apallergy.2022.12.e44

Hirono Nishiyama, Yoshihiro Kanemitsu, Kensuke Fukumitsu, Norihisa Takeda, Ryota Kurokawa, Tomoko Tajiri, Keima Ito, Jenifer Maries Go Yap, Satoshi Fukuda, Takehiro Uemura, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura, Akio Niimi

引用次数: 0

Abstract

[This corrects the article e13 in vol. 12, PMID: 35571548.].

查看原文本刊更多论文

勘误:原改为“欧洲胸科协会/美国胸科协会重度哮喘定义特征作为未来使用生物制剂/支气管热成形术的决定因素”。

[这更正了第12卷中的文章e13, PMID: 35571548]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asia Pacific Allergy ALLERGY-

CiteScore

2.50

自引率

5.90%

发文量

期刊介绍： Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.